At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 42 enrolled
Drug / intervention
Simvastatin, 80 mg/day for 21 days +1 moredrug
Likely dose
Simvastatin, 80 mg/day for 21 daysfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Statins on Cerebral Blood Flow After Subarachnoid Hemorrhage
In Brief
A Phase 2 clinical trial evaluating Simvastatin, 80 mg/day for 21 days and placebo for Subarachnoid Hemorrhage. Completed, enrolled 42 participants across 1 site.
Detailed Summary
The primary objective of this project is to investigate the effect of statin therapy on cerebral blood flow in patients with aneurysmal SAH who are randomized to receive or not receive statins in a blinded design.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubarachnoid Hemorrhage
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2008
First PostedNov 2008
Primary CompletionFeb 2013
Study CompletionDec 2013
TodayJul 2026
First PostedNov 21, 2008
Enrollment StartAug 1, 2008
Primary CompletionFeb 1, 2013
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 17.6 years ago
Interventions
Simvastatin, 80 mg/day for 21 daysdrug
Active treatment group
placebodrug
Control group